Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIDIN-PLUS vs COMBIGAN in Glaucoma or Ocular Hypertension
NCT06078592Phase 4Completed
- Sponsor
- CHA University
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brinzolamide + brimonidine in Glaucoma, ocular hypertension, sponsored by CHA University. Started Oct 2021; status: completed.
02
Drugs
brinzolamide + brimonidine
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT06078592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06078592.